These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29451036)

  • 1. Pharmaceutical-grade chondroitin sulfate in the management of knee osteoarthritis.
    Bruyère O
    Expert Opin Pharmacother; 2018 Mar; 19(4):409-412. PubMed ID: 29451036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT).
    Reginster JY; Dudler J; Blicharski T; Pavelka K
    Ann Rheum Dis; 2017 Sep; 76(9):1537-1543. PubMed ID: 28533290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study.
    Pelletier JP; Raynauld JP; Beaulieu AD; Bessette L; Morin F; de Brum-Fernandes AJ; Delorme P; Dorais M; Paiement P; Abram F; Martel-Pelletier J
    Arthritis Res Ther; 2016 Nov; 18(1):256. PubMed ID: 27809891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial.
    Sawitzke AD; Shi H; Finco MF; Dunlop DD; Bingham CO; Harris CL; Singer NG; Bradley JD; Silver D; Jackson CG; Lane NE; Oddis CV; Wolfe F; Lisse J; Furst DE; Reda DJ; Moskowitz RW; Williams HJ; Clegg DO
    Arthritis Rheum; 2008 Oct; 58(10):3183-91. PubMed ID: 18821708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial.
    Lubis AMT; Siagian C; Wonggokusuma E; Marsetyo AF; Setyohadi B
    Acta Med Indones; 2017 Apr; 49(2):105-111. PubMed ID: 28790224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responder Profile to Pharmaceutical-Grade Chondroitin Sulfate: An Analysis of the CONCEPT Trial.
    Bruyère O; Dardenne N; Donneau AF; Reginster JY
    Adv Ther; 2020 Nov; 37(11):4641-4648. PubMed ID: 32954487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib.
    Hochberg MC; Martel-Pelletier J; Monfort J; Möller I; Castillo JR; Arden N; Berenbaum F; Blanco FJ; Conaghan PG; Doménech G; Henrotin Y; Pap T; Richette P; Sawitzke A; du Souich P; Pelletier JP;
    Ann Rheum Dis; 2016 Jan; 75(1):37-44. PubMed ID: 25589511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT.
    Sawitzke AD; Shi H; Finco MF; Dunlop DD; Harris CL; Singer NG; Bradley JD; Silver D; Jackson CG; Lane NE; Oddis CV; Wolfe F; Lisse J; Furst DE; Bingham CO; Reda DJ; Moskowitz RW; Williams HJ; Clegg DO
    Ann Rheum Dis; 2010 Aug; 69(8):1459-64. PubMed ID: 20525840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the role of pharmaceutical-grade chondroitin sulfate in the symptomatic management of knee osteoarthritis.
    Honvo G; Bruyère O; Reginster JY
    Aging Clin Exp Res; 2019 Aug; 31(8):1163-1167. PubMed ID: 31243744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential effects of chondroitin sulfate on joint swelling: a GAIT report.
    Hochberg MC; Clegg DO
    Osteoarthritis Cartilage; 2008; 16 Suppl 3(0 3):S22-4. PubMed ID: 18768335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
    Clegg DO; Reda DJ; Harris CL; Klein MA; O'Dell JR; Hooper MM; Bradley JD; Bingham CO; Weisman MH; Jackson CG; Lane NE; Cush JJ; Moreland LW; Schumacher HR; Oddis CV; Wolfe F; Molitor JA; Yocum DE; Schnitzer TJ; Furst DE; Sawitzke AD; Shi H; Brandt KD; Moskowitz RW; Williams HJ
    N Engl J Med; 2006 Feb; 354(8):795-808. PubMed ID: 16495392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis.
    Bruyere O; Reginster JY
    Drugs Aging; 2007; 24(7):573-80. PubMed ID: 17658908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Non-Animal Chondroitin Sulfate Supplementation in the Treatment of Moderate Knee Osteoarthritis in a Group of Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
    Rondanelli M; Braschi V; Gasparri C; Nichetti M; Faliva MA; Peroni G; Naso M; Iannello G; Spadaccini D; Miraglia N; Putignano P; Alalwan TA; Perna S
    Nutrients; 2019 Aug; 11(9):. PubMed ID: 31470599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study.
    Mazieres B; Combe B; Phan Van A; Tondut J; Grynfeltt M
    J Rheumatol; 2001 Jan; 28(1):173-81. PubMed ID: 11196521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chondroitin sulfate on brain response to painful stimulation in knee osteoarthritis patients. A randomized, double-blind, placebo-controlled functional magnetic resonance imaging study.
    Monfort J; Pujol J; Contreras-Rodríguez O; Llorente-Onaindia J; López-Solà M; Blanco-Hinojo L; Vergés J; Herrero M; Sánchez L; Ortiz H; Montañés F; Deus J; Benito P
    Med Clin (Barc); 2017 Jun; 148(12):539-547. PubMed ID: 28237612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study.
    Martel-Pelletier J; Raynauld JP; Mineau F; Abram F; Paiement P; Delorme P; Pelletier JP
    Arthritis Res Ther; 2017 Jul; 19(1):169. PubMed ID: 28728606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo.
    Uebelhart D; Malaise M; Marcolongo R; de Vathaire F; Piperno M; Mailleux E; Fioravanti A; Matoso L; Vignon E
    Osteoarthritis Cartilage; 2004 Apr; 12(4):269-76. PubMed ID: 15023378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis.
    Bucsi L; Poór G
    Osteoarthritis Cartilage; 1998 May; 6 Suppl A():31-6. PubMed ID: 9743817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial.
    Kahan A; Uebelhart D; De Vathaire F; Delmas PD; Reginster JY
    Arthritis Rheum; 2009 Feb; 60(2):524-33. PubMed ID: 19180484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study.
    Zegels B; Crozes P; Uebelhart D; Bruyère O; Reginster JY
    Osteoarthritis Cartilage; 2013 Jan; 21(1):22-7. PubMed ID: 23059756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.